NeueHealth Past Earnings Performance
Past criteria checks 3/6
NeueHealth's earnings have been declining at an average annual rate of -13.1%, while the Healthcare industry saw earnings growing at 5.7% annually. Revenues have been declining at an average rate of 7.5% per year.
Key information
-13.1%
Earnings growth rate
22.9%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -7.5% |
| Return on equity | n/a |
| Net Margin | 2.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Bright Health Group: Stock Price Has Been Too Heavily Beaten Down
Jan 19Bright Health Group expects FY23 revenue to be below consensus
Jan 10Bright Health receives non-compliance notice from NYSE
Dec 12Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance
Nov 09Bright Health narrows footprint to only offer Medicare Advantage in California, Florida
Oct 11Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report
Aug 13
Bright Health Group Takes Cost Actions To Effect Turnaround
Jul 21Revenue & Expenses Breakdown
How NeueHealth makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 997 | 28 | 271 | 0 |
| 30 Jun 24 | 1,033 | -495 | 302 | 0 |
| 31 Mar 24 | 1,105 | -510 | 302 | 0 |
| 31 Dec 23 | 1,161 | -563 | 315 | 0 |
| 30 Sep 23 | 1,096 | -825 | 338 | 0 |
| 30 Jun 23 | 1,020 | -407 | 328 | 0 |
| 31 Mar 23 | 871 | -447 | 337 | 0 |
| 31 Dec 22 | 751 | -521 | 354 | 0 |
| 30 Sep 22 | -1,031 | -373 | 9 | 0 |
| 30 Jun 22 | -145 | -513 | 233 | 0 |
| 31 Mar 22 | 819 | -450 | 415 | 0 |
| 31 Dec 21 | 1,513 | -330 | 527 | 0 |
| 30 Sep 21 | 3,427 | -534 | 924 | 0 |
| 30 Jun 21 | 2,700 | -293 | 712 | 0 |
| 31 Mar 21 | 1,883 | -266 | 539 | 0 |
| 31 Dec 20 | 515 | -161 | 221 | 0 |
| 31 Dec 19 | 281 | -125 | 180 | 0 |
| 31 Dec 18 | 131 | -63 | 96 | 0 |
Quality Earnings: NEUE has high quality earnings.
Growing Profit Margin: NEUE became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEUE has become profitable over the past 5 years, growing earnings by -13.1% per year.
Accelerating Growth: NEUE has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: NEUE has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (10.2%).
Return on Equity
High ROE: NEUE's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 19:08 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeueHealth, Inc. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |
| Kevin Fischbeck | BofA Global Research |